Marker Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $1,103 | $1,232 |
Gross Profit | -2,842 | -1,112 | |
EBITDA | -3,179 | -1,718 | -1,998 |
EBIT | -1,998 | ||
Net Income | -3,179 | -1,703 | -1,998 |
Net Change In Cash | 0 | 1,103 | 1,232 |
Free Cash Flow | -1,404 | -1,900 | -2,735 |
Cash | 14,915 | 16,068 | 17,589 |
Basic Shares | 19,314 | 15,310 | 16,757 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $3,546 | $6,591 | $3,311 | $3,513 |
Gross Profit | -6,876 | -7,105 | -8,454 | |
EBITDA | -12,437 | -10,681 | -11,253 | -16,986 |
EBIT | -10,681 | -14,042 | -19,775 | |
Net Income | -12,163 | -10,731 | -8,236 | -29,930 |
Net Change In Cash | 3,546 | 6,591 | 3,311 | 3,513 |
Free Cash Flow | -12,014 | -10,910 | -16,439 | -26,972 |
Cash | 16,068 | 19,192 | 15,111 | 11,782 |
Basic Shares | 15,310 | 8,980 | 8,809 | 8,351 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.09 |
2026-03-31 | -$0.16 |
2025-12-31 | -$0.04 |
2025-09-30 | -$0.12 |